Pharmamarketeer

Breakthrough study on molecular interactions could improve development of new medicines

Molecular interactions

A first-of-its-kind study on molecular interactions by biomedical engineers in the University of Minnesota’s College of Science and Engineering will make it easier and more efficient for scientists to develop new medicines and other therapies for diseases such as cancer, HIV, and autoimmune diseases.

Medhc-fases-banner
Advertentie(s)